Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
09/2011
09/20/2011CA2645856C Pyrazoles as 11-beta-hsd-1
09/20/2011CA2541458C Pyrrole and pyrazole derivatives as potentiators of glutamate receptors
09/20/2011CA2509225C Indol derivatives and their use as 5-ht ligands
09/20/2011CA2505368C Trans-9,10-dehydroepothilone c and d, analogs thereof and methods of making the same
09/20/2011CA2503868C Sulfonamides, sulfamates and sulfamides as gamma-secretase inhibitors
09/20/2011CA2478979C Detection of glucose in solutions also containing an alpha-hydroxy acid or a beta-diketone
09/20/2011CA2471943C .beta.-amyloid protein production-secretion inhibitors
09/20/2011CA2462903C Beta-lactamyl vasopressin v1a antagonists
09/20/2011CA2461812C 3-(arylamino)methylene-1,3-dihydro-2h-indol-2-ones as kinase inhibitors
09/20/2011CA2443403C 5-membered heterocycles, preparation and use thereof as mao inhibitors and lipid peroxidation inhibitors, preparation thereof and use thereof as medicaments
09/20/2011CA2440067C Quinolyl propyl piperidine derivatives, the preparation thereof and compositions containing same
09/20/2011CA2439415C Cathepsin cysteine protease inhibitors
09/15/2011WO2011112966A1 Bioluminescent assays using cyanobenzothiazole compounds
09/15/2011WO2011112761A1 Crystalline salts of a potent hcv inhibitor
09/15/2011WO2011112685A1 4,4-disubstituted piperidine derivatives useful as inhibitors of dipeptidyl peptidase-1 (dpp-1)
09/15/2011WO2011112191A1 Compounds for the treatment of hepatitis c
09/15/2011WO2011111875A1 N-acyl cyclic amine derivative or pharmaceutically acceptable salt thereof
09/15/2011WO2011110612A1 Inhibitors of protein kinases
09/15/2011WO2011110575A1 Derivatives of 2-[2-(benzo- or pyrido-) thiazolylamino]-6-aminopyridine, useful in the treatment of respiratoric, allergic or inflammatory diseases
09/15/2011WO2010089303A9 CYCLIC INHIBITORS OF 11 β-HYDROXYSTEROID DEHYDROGENASE 1
09/15/2011US20110224263 Cyclic pyridyl-N-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
09/15/2011US20110224259 Novel inhibitors
09/15/2011US20110224257 Bis(difluoromethyl)pyrazoles as Fungicides
09/15/2011US20110224255 Tripeptidyl peptidase inhibitors
09/15/2011US20110224241 Isothiazole and pyrazole derivatives as fungicides
09/15/2011US20110224233 Stem cell cultures
09/15/2011US20110224230 Bicyclic dihydroimidazolone cgrp receptor antagonists
09/15/2011US20110224225 Inhibitors of protein kinases
09/15/2011US20110224211 Anti-Viral Compounds, Compositions, And Methods Of Use
09/15/2011US20110224209 4,4-disubstituted piperidine derivatives useful as inhibitors of dipeptidyl peptidase-1 (dpp-1)
09/15/2011US20110224208 Novel inhibitors of flavivirus replication
09/15/2011US20110224207 Flavivirus inhibitors and methods for their use
09/15/2011US20110224204 Di-substituted phenyl compounds
09/15/2011US20110224202 Pde10 inhibitors and related compositions and methods
09/15/2011US20110224198 Aryl methyl benzoquinazolinine m1 receptor positive allosteric modulators
09/15/2011US20110224197 Pyrimidines and pyridines useful as inhibitors of protein kinases
09/15/2011US20110224187 Pyrrolidine, piperidine and piperazine derivatives and methods of use thereof
09/15/2011US20110223221 Stabilization processes of cation radicals of phenothiazinic compounds, cosmeceutical formulations and methods for skin diseases and disturbances prevention
09/15/2011CA2792844A1 Pde10 inhibitors and related compositions and methods
09/15/2011CA2792684A1 Crystalline salts of a potent hcv inhibitor
09/15/2011CA2792539A1 N-acyl cyclic amine derivative or pharmaceutically acceptable salt thereof
09/15/2011CA2789189A1 Inhibitors of protein kinases
09/14/2011EP2365735A2 Luminescent element material and luminescent element comprising the same
09/14/2011EP2364979A1 Pyrrole compounds
09/14/2011EP2364976A1 S1P receptor modulating compounds and use thereof
09/14/2011EP2364974A1 N-(3-Phenylamino-quinoxalin-2-yl)-benzenesulfonamide derivatives as phosphatidylinositol 3-kinase inhibitors
09/14/2011EP2364310A2 4-amino-4-oxobutanoyl peptide cyclic analogues, inhibitors of viral replication
09/14/2011EP2364309A2 New 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
09/14/2011EP2364308A1 Pyrazine compounds as phosphodiesterase 10 inhibitors
09/14/2011EP2364306A1 Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors
09/14/2011EP2364297A1 Compounds, pharmaceutical composition and methods for use in treating metabolic disorders
09/14/2011EP2164847B1 3-aza-bicyclo[3.3.0]octane compounds
09/14/2011EP2139880B1 Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
09/14/2011EP2079731B1 Novel substituted piperidyl-propane-thiols
09/14/2011EP1911755B1 Benzoimidazole compound capable of inhibiting prostaglandin d synthetase
09/14/2011EP1896421B1 Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met
09/14/2011EP1689387B1 Bicyclic inhibitors of mek and methods of synthesis thereof
09/14/2011EP1534277B1 Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
09/14/2011EP1471915B1 2,4-pyrimidinediamine compounds and their uses
09/14/2011EP1346982B1 Vla-4 inhibitors
09/14/2011CN1938279B Modulators of atp-binding cassette transporters
09/14/2011CN1898206B Allosteric modulators of metabotropic glutamate receptors
09/14/2011CN1802187B Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors
09/14/2011CN102186847A New 2-amidothiadiazole derivatives
09/14/2011CN102186839A Azetidine polysubstituted compounds, preparation thereof, and therapeutic application thereof
09/14/2011CN102186823A Heterocyclic antiviral arylpyridone derivatives
09/14/2011CN102186816A Pesticidal (hetero) arylpyrrolidines
09/14/2011CN102186475A Novel inhibitors
09/14/2011CN102180872A [1, 3 and 4] oxadiazoles derivative and application thereof
09/14/2011CN102180871A 4-methyl-1,2,3-thiadiazole urea derivatives and preparation method and application thereof
09/14/2011CN102180870A (4-[2-(aryl-methyl amine)-4-methyl-thiazole-5]-pyrimidine-2)-arylamine derivative and preparation method and pharmaceutical application thereof
09/14/2011CN102180828A Chiral indolinone spiropentacyclic skeleton compounds and asymmetric synthesis thereof
09/14/2011CN101759695B Thiazole derivative containing pyrazole ring and preparation method and application thereof
09/14/2011CN101624376B Substituted hydrazide compound and application thereof
09/14/2011CN101506170B 6-(heterocycle-substituted benzyl)-4-oxoquinoline compound and use of the same as HIV integrase inhibitor
09/14/2011CN101328170B Fluorophenyl-substituted thiazole dihydropyrimidine
09/14/2011CN101291676B Amidines derivative and use of medicine
09/14/2011CN101163696B Histone deacetylase inhibitors
09/13/2011US8017771 Process for preparing acyclic HCV protease inhibitors
09/13/2011US8017769 Colorless water-soluble organic luminophores and intermediates thereof
09/13/2011US8017637 Inhibitors of cdc phosphatases
09/13/2011US8017629 Compounds and uses thereof in modulating amyloid β
09/13/2011US8017628 Pharmaceutically active sulfonyl hydrazide derivatives
09/13/2011US8017608 5-Phenylthiazole derivatives and their use as p13 kinase inhibitors
09/13/2011CA2670605C Substituted arylpyrazoles
09/13/2011CA2570717C Cetp inhibitors
09/13/2011CA2452606C Tetrahydroquinoline derivatives
09/13/2011CA2441565C Bisarylamines as potassium channel openers
09/13/2011CA2440238C Novel amines as histamine-3 receptor ligands and their therapeutic applications
09/09/2011WO2011109470A1 Heteroaryl nitrile compounds useful as inhibitors of cathepsin-s
09/09/2011WO2011108613A1 Photoelectric conversion element and photoelectrochemical cell
09/09/2011WO2011108612A1 Photoelectric conversion element and photoelectrochemical cell
09/09/2011WO2011108611A1 Photoelectric conversion element and photoelectrochemical cell
09/09/2011WO2011108236A1 Radioactive iodine labeled organic compound or salt thereof
09/09/2011WO2011107530A2 Novel inhibitors
09/09/2011WO2011107248A1 NOVEL COMPOUNDS FOR MODULATION OF ORPHAN NUCLEAR RECEPTOR RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORγ GAMMA, NR1F3) ACTIVITY AND FOR THE TREATMENT OF CHRONIC INFLAMMATORY AND AUTOIMMUNE DISEASE
09/09/2011CA2791738A1 Compounds for treatment of cancer
09/09/2011CA2791672A1 Positive allosteric modulators of mglur2
09/09/2011CA2791491A1 Radioactive iodine-labeled organic compound or salt thereof
09/08/2011US20110218343 Small molecule inhibitors of rotamase enzyme activity